Assure (US:IONM)2024-06-07 19:34Business Operations - Assure Holdings Corp. provides Intraoperative neuromonitoring (IONM) services, which are essential for various surgical procedures, ensuring patient safety and risk mitigation [127]. - Each Intraoperative Neurophysiologist (INP) can support approximately 200 cases annually, while supervising practitioners can monitor around 2,500 cases per year [131][132]. - Assure exited the majority of its legacy Managed Service Agreement (MSA) model in 2023, aiming to retain all revenue from the Professional Component of IONM services [134]. Financial Performance - The company has modernized its revenue cycle management, leading to successful state-level arbitrations in 2022 and federal arbitrations in 2023, enhancing its financial performance [133]. - Total revenue for Q1 2024 was $9 thousand, a decrease of 92% from $115 thousand in Q1 2023, attributed to the company's exit from managed service arrangements [147]. - Cost of revenues decreased by 30% to $475 thousand in Q1 2024 from $679 thousand in Q1 2023, primarily due to a reduction in headcount [148]. - General and administrative expenses increased by 22% to $3.9 million in Q1 2024 from $3.2 million in Q1 2023, mainly due to higher legal fees related to asset sales and proposed mergers [149]. - The company recorded a gain of $181 thousand from the settlement of accounts payable in Q1 2024, with no such gains in Q1 2023 [150]. - Interest expense rose by 5% to $527 thousand in Q1 2024 from $501 thousand in Q1 2023, driven by higher outstanding debt balances [151]. - Income tax benefit was nil in Q1 2024, compared to $796 thousand in Q1 2023, reflecting changes in taxable income across jurisdictions [153]. - Income from discontinued operations increased by 114% to $908 thousand in Q1 2024 from $425 thousand in Q1 2023, bolstered by a $666 thousand gain on asset sales [155]. - The company's cash position improved to $376 thousand as of March 31, 2024, up from $123 thousand at the end of 2022, but working capital remained negative at $19 million [158]. - Cash collected from receivables for Q1 2024 was approximately $3.9 million, down from $4.5 million in Q1 2023 [170]. - Accounts receivable as of March 31, 2024, was $2.1 million, a decrease from $3.6 million at December 31, 2023, attributed to increased cash receipt velocity [171]. - Cash used in operating activities for Q1 2024 was $1.5 million, compared to $497 thousand in Q1 2023 [171]. - Cash provided by investing activities for Q1 2024 was $2.3 million, primarily from the sale of clinical assets, compared to $37 thousand in Q1 2023 [172]. - Cash used in financing activities for Q1 2024 was $603 thousand, including debt repayment of $82 thousand and finance lease principal payments of $408 thousand [173]. - The company has no material undisclosed off-balance sheet arrangements that could affect its financial condition [174]. Compliance and Governance - The company is currently not in compliance with Nasdaq listing requirements, facing potential delisting if compliance is not regained by July 22, 2024 [160]. - A material weakness in internal control over financial reporting was identified, prompting a rigorous review process for complex transactions [180][182]. - The company is currently addressing non-compliance with NASDAQ listing requirements, including a minimum bid price of $1.00 per share [188][191]. - The company has until January 22, 2024, to regain compliance with NASDAQ's minimum bid price requirement [191]. - A settlement agreement with the U.S. Department of Justice was executed for approximately $1 million, resolving claims under the False Claims Act [186]. Strategic Developments - In September 2023, Assure's Board initiated a strategic review process, leading to an auction for the sale of its clinical operations, which was completed on March 26, 2024 [135]. - Following the merger with Danam Health, Assure will be renamed Danam Health Holdings Corp., with former Danam equity holders expected to own approximately 90% of the combined company [139][138]. - The merger agreement includes customary representations and covenants, ensuring compliance with NASDAQ listing requirements [140]. - The company is seeking equity or debt financing to support operations, with a potential $3.2 million refund under the CARES Act Employee Retention Credit program pending [158].